Research Topics
Genomes and Genes
| biological tumor markersSummarySummary: Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids. Top Publications
Research Grants
| Scientific Experts
|
Detail Information
Publications
Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survivalM A Elkablawy
Quantitative Biomarkers Group, Department of Pathology, Cancer Research Centre, Queen's University of Belfast, Grosvenor Road, Belfast BT12 6BL, UK
J Pathol 194:436-43. 2001..In conclusion, bcl-2 immunoreactivity was associated with apoptosis and could be used in combination with Dukes' stage as a means of predicting prognosis in colorectal cancer...
Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancerJunjie Peng
Department of Abdominal Surgery, Cancer Hospital of Fudan University, Shanghai Medical College, Fudan University, Shanghai, China
Cancer J 14:54-61. 2008..The purpose of this study was to investigate the significance of CD44 variant 6 (CD44v6) in predicting the treatment outcome of locally advanced adenocarcinoma of the rectum after total mesorectal excision (TME)...
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data setsClaus Lindbjerg Andersen
Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark
Cancer Res 64:5245-50. 2004..The presented strategy can be applied to evaluate the suitability of any normalization gene candidate in any kind of experimental design and should allow more reliable normalization of RT-PCR data...
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cellsMichael F Clarke
Stanford University School of Medicine, Stanford, California, USA
Cancer Res 66:9339-44. 2006
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancerD J Slamon
Department of Medicine, U C L A School of Medicine 90024
Science 244:707-12. 1989..The data presented further support the concept that the HER-2/neu gene may be involved in the pathogenesis of some human cancers...
Triple-negative breast cancer: clinical features and patterns of recurrenceRebecca Dent
Department of Medical Oncology, Sunnybrook Health Sciences Center, University of Toronto, Ontario, Canada
Clin Cancer Res 13:4429-34. 2007..To compare the clinical features, natural history, and outcomes for women with "triple-negative" breast cancer with women with other types of breast cancer...
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaTorsten O Nielsen
Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Clin Cancer Res 10:5367-74. 2004..These studies show that many basal-like tumors express HER1, which suggests candidate drugs for evaluation in these patients...
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinomaDanit Lebanony
Rosetta Genomics Ltd, 10 Plaut St, Rehovot 76706, Israel
J Clin Oncol 27:2030-7. 2009..In this study, we set out to identify specific microRNA biomarkers for the identification of squamous cell carcinoma, and to use such markers for the development of a standardized assay...
Unique microRNA molecular profiles in lung cancer diagnosis and prognosisNozomu Yanaihara
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Cancer Cell 9:189-98. 2006..These results indicate that miRNA expression profiles are diagnostic and prognostic markers of lung cancer...
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancerSoonmyung Paik
Division of Pathology, Operation Center, and the Biostatistics Center, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh 15212, USA
N Engl J Med 351:2817-26. 2004..The likelihood of distant recurrence in patients with breast cancer who have no involved lymph nodes and estrogen-receptor-positive tumors is poorly defined by clinical and histopathological measures...
Use of immunohistochemical markers can refine prognosis in triple negative breast cancerMarc Tischkowitz
Program in Cancer Genetics, McGill University, Montreal, Quebec, Canada
BMC Cancer 7:134. 2007..The IHC pattern that best defines basal-like tumors is under investigation and various combinations of ER, PR, HER2-, CK5/6+ and EGFR+ have been tested...
Enabling personalized cancer medicine through analysis of gene-expression patternsLaura J Van't Veer
Agendia BV, Louwesweg 6, 1066 EC Amsterdam, The Netherlands
Nature 452:564-70. 2008..In particular, tests that predict the clinical outcome for patients on the basis of the genes expressed by their tumours are likely to increasingly affect patient management, heralding a new era of personalized medicine...
The Ki-67 protein: from the known and the unknownT Scholzen
Division of Molecular Immunology, Research Center Borstel, Germany
J Cell Physiol 182:311-22. 2000..There are indications, however, that Ki-67 protein expression is an absolute requirement for progression through the cell-division cycle...
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsBryan T Hennessy
Department of Gynecologic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Cancer Res 69:4116-24. 2009..PIK3CA mutations, EMT, and stem cell-like characteristics likely contribute to the poor outcomes of MBC and suggest novel therapeutic targets...
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiationTiffany M Phillips
Department of Radiation Oncology, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, Los Angeles, CA 90095-1714, USA
J Natl Cancer Inst 98:1777-85. 2006..These findings offer a possible mechanism for the accelerated repopulation of tumor cells observed during gaps in radiotherapy...
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu
Ovarian Cancer Research Laboratory, Department of Experimental Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 10:3291-300. 2004..CONCLUSIONS: Our data are consistent with the possibility that a limited number of markers in combination might identify >99% of epithelial ovarian cancers despite the heterogeneity of the disease...
Assessment of a HER2 scoring system for gastric cancer: results from a validation studyM Hofmann
Institute of Pathology, Klinikum Kassel, Kassel, Germany
Histopathology 52:797-805. 2008..The aim was to establish a HER2 scoring system for gastric cancer to identify suitable patients for enrollment in a trial of trastuzumab (Herceptin) in advanced metastatic gastric cancer...
Cell surface tumor endothelial markers are conserved in mice and humansE B Carson-Walter
The Howard Hughes Medical Institute, Baltimore, Maryland 21231, USA
Cancer Res 61:6649-55. 2001..The coordinate expression of TEM1, TEM5, and TEM8 on tumor endothelium in humans and mice makes these genes attractive targets for the development of antiangiogenic therapies...
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinomaAaron J Schetter
Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
JAMA 299:425-36. 2008..MicroRNAs have potential as diagnostic biomarkers and therapeutic targets in cancer. No study has evaluated the association between microRNA expression patterns and colon cancer prognosis or therapeutic outcome...
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang
Genetic Pathology Evaluation Centre, Vancouver Coastal Health Research Institute, British Columbia Cancer Agency, and University of British Columbia, Vancouver, British Columbia, Canada
Clin Cancer Res 14:1368-76. 2008..This study directly compares the prognostic significance between three- and five-biomarker surrogate panels to define intrinsic breast cancer subtypes, using a large clinically annotated series of breast tumors...
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic targetC Gravalos
Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain
Ann Oncol 19:1523-9. 2008..This review summarizes the rationale, preclinical evidence, retrospective clinical analyses, and the interim clinical data pertaining HER2 therapies in gastric cancer...
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancerGennadi V Glinsky
Sidney Kimmel Cancer Center, San Diego, California 92121, USA
J Clin Invest 115:1503-21. 2005....
Development of personalized tumor biomarkers using massively parallel sequencingRebecca J Leary
Ludwig Center for Cancer Genetics and Therapeutics and Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA
Sci Transl Med 2:20ra14. 2010..This approach provides an exquisitely sensitive and broadly applicable approach for the development of personalized biomarkers to enhance the clinical management of cancer patients...
Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virusFrancine Walker
Department of Pathology, Institut de la Santé et de la Recherche Médicale Unité773, Hopital Bichat Claude Bernard, 75018 Paris, France
Hum Pathol 40:1517-27. 2009..The finding that EGFR, c-Met, and VEGFR1 involved in carcinogenesis are well-represented and coexpressed in anal cancers, especially in HIV-positive population, suggests possible novel targeted treatments for anal diseases...
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancerJohan Staaf
Department of Oncology, Clinical Sciences, Lund University, Barngatan 2B, Lund, Sweden
Breast Cancer Res 12:R25. 2010....
Symbiotic bacteria direct expression of an intestinal bactericidal lectinHeather L Cash
Center for Immunology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
Science 313:1126-30. 2006..We propose that these proteins represent an evolutionarily primitive form of lectin-mediated innate immunity, and that they reveal intestinal strategies for maintaining symbiotic host-microbial relationships...
Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53S W Beenken
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
Ann Surg 233:630-8. 2001..To assess the prognostic significance of molecular biomarkers, particularly c-erbB-2 and p53, through study of prospective clinical data and archival breast cancer tissues for women accrued to the Alabama Breast Cancer Project...
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityShengyong Yin
Department of General Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, People s Republic of China
Int J Cancer 120:1444-50. 2007..The implication that CD133 might be one of the markers for HCC cancer stem-like cells needed further investigation...
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancerYing Xie
Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA
Lung Cancer 67:170-6. 2010..82% sensitivity and 100.00% specificity by sputum cytology. The measurement of altered miRNA expression in sputum could be a useful noninvasive approach for the diagnosis of lung cancer...
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomasBas Kreike
Division of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Breast Cancer Res 9:R65. 2007..We examined the histopathological and gene-expression profile of triple-negative tumors to define subgroups with specific characteristics, including risk of developing distant metastases...
Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study designMargaret S Pepe
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Natl Cancer Inst 100:1432-8. 2008..Common biases that pervade the biomarker research literature would be eliminated if these rigorous standards were followed...
FOXA1 expression in breast cancer--correlation with luminal subtype A and survivalSunil Badve
Department of Pathology, Indiana University School of Medicine, Indianapolis, USA
Clin Cancer Res 13:4415-21. 2007..It segregates with genes that characterize the luminal subtypes in DNA microarray analyses. The utility of FOXA1 as a possible independent prognostic factor has not been determined in breast cancers...
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomasKeith Hoek
Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, 15 York Street, New Haven, CT 06520-8059, USA
Cancer Res 64:5270-82. 2004..These results provide a comprehensive view of changes in advanced melanoma relative to normal melanocytes and reveal new targets that can be used in assessing prognosis, staging, and therapy of melanoma patients...
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancerMichail Ignatiadis
Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Crete, Greece
Clin Cancer Res 14:2593-600. 2008..To investigate the prognostic value of the molecular detection of circulating tumor cells (CTCs) using three markers [cytokeratin 19 (CK19), mammaglobin A (MGB1), and HER2] in early breast cancer...
Expression of progesterone receptor is a favorable prognostic marker in ovarian cancerPeng Lee
Department of Pathology, New York University Medical Center, New York, NY 10003, USA
Gynecol Oncol 96:671-7. 2005..0001) in univariate and multivariate analyses. CONCLUSIONS: The PR is an independent marker, with its overexpression associated with a favorable prognosis in women with ovarian cancer...
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancerAlex Soltermann
Institute for Surgical Pathology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland
Clin Cancer Res 14:7430-7. 2008....
Basal carcinoma of the breast revisited: an old entity with new interpretationsE Korsching
Institute of Pathology, University of Muenster, Germany
J Clin Pathol 61:553-60. 2008..Clinical consequences and potential future research directions driven by the definition of basal breast cancers will also be discussed...
Differential expression of microRNA species in human gastric cancer versus non-tumorous tissuesJunming Guo
Ningbo University School of Medicine, Ningbo 315211, Zhejiang Province, China
J Gastroenterol Hepatol 24:652-7. 2009..MicroRNAs (miRNAs) play important roles in carcinogenesis. The global miRNA expression profile of gastric cancer has not been reported. The purpose of the present study was to determine the miRNA expression profile of gastric cancer...
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarraysAnders Carlsson
Department of Immunotechnology, Lund University, BMC D13, SE 221 84 Lund, Sweden
Eur J Cancer 44:472-80. 2008..In a longer perspective, antibody microarray analysis could provide a tool for the development of improved diagnostics and intensified biomarker discovery for breast cancer patients...
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic massRichard G Moore
Women and Infants Hospital, Brown University, Providence, RI 02925, USA
Gynecol Oncol 108:402-8. 2008..Because elevated CA125 levels occur in many benign gynecologic conditions, we set out to identify other novel biomarkers that would increase the sensitivity and specificity of CA125...
A novel five-antibody immunohistochemical test for subclassification of lung carcinomaBrian Z Ring
Department of Research and Development, Applied Genomics Inc, Burlingame, CA 94010, USA
Mod Pathol 22:1032-43. 2009..The results also suggest that if validated in prospectively defined clinical trials this classifier might identify candidates for targeted therapy that are overlooked with current diagnostic approaches...
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neckPernille Lassen
Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
J Clin Oncol 27:1992-8. 2009....
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancerB S M S Siriwardena
Department of Oral Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, 1 2 3 Kasumi, Hiroshima, Japan
Br J Cancer 95:1396-403. 2006..In summary, these findings suggest that Periostin may promote invasion and angiogenesis in OSCC, and that Periostin can be a strong marker for prediction of metastasis in oral cancer patients...
Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysisA Takeno
Department of Surgery, Graduate School of Medicine, Osaka University, 2 2 Yamadaoka Suita, Osaka 565 0871, Japan
Br J Cancer 99:1307-15. 2008..This integrated approach could help to identify candidate players in gastric carcinogenesis and progression. These genes are potential markers of gastric cancer regardless of stage...
Application of mesothelin immunostaining in tumor diagnosisNelson G Ordonez
University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Am J Surg Pathol 27:1418-28. 2003..Finally, the strong mesothelin reactivity seen in the adenomatoid tumors (3 of 3) provides further support for a mesothelial derivation for this lesion...
Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discoveryJulio E Celis
Danish Centre for Translational Breast Cancer Research, and Department of Proteomics in Cancer, Institute of Cancer Biology, The Danish Cancer Society, DK 2100 Copenhagen, Denmark
Mol Cell Proteomics 3:327-44. 2004....
A review and update on cholangiocarcinomaMatthew J Olnes
Department of Internal Medicine, Johns Hopkins Bayview Medical Center and Johns Hopkins School of Medicine, Baltimore, MD, USA
Oncology 66:167-79. 2004..Particular focus is on recent studies into the cellular and molecular pathogenesis of the disease, recent chemotherapy trials, and newer methods of staging and screening for this devastating malignancy...
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerK S Goonetilleke
Department of Surgery, Hepatobiliary Surgical Unit, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK
Eur J Surg Oncol 33:266-70. 2007..This systematic review examines studies using biochemical markers for the diagnosis of pancreatic cancer in order to appraise their role in contemporary management algorithms...
Mesothelin-family proteins and diagnosis of mesotheliomaBruce W S Robinson
University Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Western Australia, Perth, Australia
Lancet 362:1612-6. 2003..Identification of such a marker would be useful in diagnosis of mesothelioma and for monitoring responses to treatment and screening at-risk individuals...
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysisA P Meert
Dept of Internal Medicine, Jules Bordet Institute, Brussels, Belgium
Eur Respir J 20:975-81. 2002..Epidermal growth factor receptor might be a poor prognostic factor for survival in nonsmall-cell lung cancer. The amplitude of the impact is small, however, and may be subject to publication bias...
Plastins: versatile modulators of actin organization in (patho)physiological cellular processesVeerle Delanote
Department of Medical Protein Research, Flanders Interuniversity Institute for Biotechnology (VIB, Ghent University, Faculty of Medicine and Health Sciences, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium
Acta Pharmacol Sin 26:769-79. 2005..T-plastin, on the other hand, is possibly involved in DNA repair. Finally, both T- and L-plastin are implicated in several diseases, and L-plastin is considered to be a valuable marker for cancer...
Regulation of ovarian function: the role of anti-Müllerian hormoneAlexandra L L Durlinger
Department of Internal Medicine, Erasmus MC, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Reproduction 124:601-9. 2002....
Reporting recommendations for tumor marker prognostic studies (REMARK)Lisa M McShane
Biometric Research Branch, National Cancer Institute, Executive Plaza North, 6130 Executive Blvd, Bethesda, MD 20892 7434, USA
J Natl Cancer Inst 97:1180-4. 2005....
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinomaMariana Capurro
Division of Molecualr and Cell Biology, Sunnybrook and Women's College Health Sciences Center and Deaprtment of Medical Biophysics, University of Toronto, Ontario, Canada
Gastroenterology 125:89-97. 2003..The simultaneous determination of GPC3 and AFP may significantly increase the sensitivity for diagnosis of HCC...
Periostin: novel diagnostic and therapeutic target for cancerY Kudo
Department of Oral and Maxillofacial Pathobiology, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
Histol Histopathol 22:1167-74. 2007..This review summarizes the recent understanding of Periostin roles in tumor development and speculates on the usefulness of Periostin as a therapeutic and diagnostic target for cancer...
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomasM F Press
Norris Comprehensive Cancer Center and Department of Pathology, University of Southern California School of Medicine, Los Angeles, CA 90033, USA
J Clin Oncol 15:2894-904. 1997....
Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detectionShawn A Ritchie
Phenomenome Discoveries Inc, Saskatoon, SK, Canada
BMC Med 8:13. 2010..Using tandem-mass spectrometry (MS/MS) high throughput MS technology we evaluated the utility of selected markers and this technology for discriminating between CRC and healthy subjects...
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypesEmad A Rakha
Department of Histopathology, Nottingham City Hospital NHS Trust, Nottingham University, Nottingham, United Kingdom
Clin Cancer Res 15:2302-10. 2009..It is widely perceived that BLBC and TN tumors are synonymous and BLBC can be defined using a TN definition without the need for the expression of basal markers...
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel
Department of Pathology, Genetic Pathology Evaluation Centre of the Prostate Research Centre, Vancouver General Hospital and British Columbia Cancer Agency, Vancouver, British Columbia, Canada
PLoS Med 5:e232. 2008..We examined variation in biomarker expression rates between subtypes, and how this influences correlations between biomarker expression and stage at diagnosis or prognosis...
Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNAKatrin Panzitt
Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, A 8036 Graz, Austria
Gastroenterology 132:330-42. 2007..We searched the human genome for novel genes including ncRNAs related to hepatocellular carcinoma (HCC)...
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcomeRichard W Tothill
Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Australia
Clin Cancer Res 14:5198-208. 2008..The study aim to identify novel molecular subtypes of ovarian cancer by gene expression profiling with linkage to clinical and pathologic features...
MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone statusTone F Bathen
Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7489 Trondheim, Norway
Breast Cancer Res Treat 104:181-9. 2007..MR-determined metabolic phenotype may have a future role as a supplement for clinical decision-making-concerning adjuvant treatment and the adaptation to more individualised treatment protocols...
Transcriptome profile of human colorectal adenomasJacob Sabates Bellver
Institute of Molecular Cancer Research, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland
Mol Cancer Res 5:1263-75. 2007....
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinomaM J Wallard
Department of Oncology, Hutchison MRC Research Centre, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK
Br J Cancer 94:569-77. 2006..This work forms the basis for further functional studies, which will help to confirm the MMPs as potential diagnostic and therapeutic targets in early bladder cancer...
Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancerNuran Bektas
Institute of Pathology, University Hospital of the RWTH Aachen, Aachen, Germany
BMC Cancer 8:42. 2008....
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcomeKim L Wang
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 109:658-67. 2007..It is not known whether EGFR plays a similar role in esophageal and EGJ adenocarcinomas...
E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagusK Evangelou
Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, University of Athens, Greece
J Clin Pathol 61:601-5. 2008..To date there are no data regarding E2F-1 expression and its relationship with tumour kinetics (proliferation, apoptosis) in adenocarcinomas that develop on Barrett oesophagus...
Survivin expression is associated with bladder cancer presence, stage, progression, and mortalityShahrokh F Shariat
Department of Urology, University of Texas Southwestern Medical Center at Dallas, Texas 75390 9110, USA
Cancer 109:1106-13. 2007....
Osteopontin-c is a selective marker of breast cancerMana Mirza
College of Pharmacy, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
Int J Cancer 122:889-97. 2008..In conjunction, osteopontin-c, ER and HER2 reliably predict grade 2-3 breast cancer. Hence, osteopontin-c is a diagnostic and prognostic marker that may have value in a diagnostic panel together with conventional breast cancer markers...
Study of HER2/neu status in Qatari women with breast carcinomaKakil I Rasul
Department of Medicine Hematology Oncology Section, PO Box 3050, Doha, Qatar
Saudi Med J 24:832-6. 2003..The study is aimed at determining the prevalence of HER2/neu overexpression in Qatari women with breast cancer and to assess the survival in patients with HER2/neu positive tumors...
C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancerAngela F Logullo
Departamento de Patologia da Universidade Federal de São Paulo, Sao Paulo, Brazil
Oncol Rep 18:121-6. 2007....
Prostanoid receptor EP1 expression in breast cancerMangesh A Thorat
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Mod Pathol 21:15-21. 2008..059). Expression of EP1 is frequently seen in human breast cancers. Nuclear expression of EP1 correlates with good prognosis markers like node negative status and PR expression...
Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patientsYung Chang Lin
Division of Hematology Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, 199 Tung Hwa North Road, Taipei 105, Taiwan
Cancer Sci 94:99-102. 2003..Further evaluation of hMAM mRNA in combination with other molecular markers to follow post-operative breast cancer patient is warranted...
Down-regulation of fragile histidine triad expression in prostate carcinomaRebecca L Fouts
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
Cancer 97:1447-52. 2003..Numerous studies have indicated that the FHIT gene on chromosome 3p may play an important role in human neoplasia, although very few studies have investigated the FHIT gene in prostate carcinoma...
The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical studyS F Morris
National Breast Cancer Research Institute (NBCRI, University College Hospital, Galway, Ireland
Eur J Surg Oncol 27:527-31. 2001..The increased expression of variant CD44 isoforms seen in breast neoplasia may merely be a marker for loss of control of alternative splicing within tumour tissue...
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinomaE Bollito
Dipartimento di Anatomia Patologica, , Orbassano, Italy
Ann Oncol 12:S159-64. 2001..03) particularly in metastatic cases. CONCLUSIONS: These data support the concept that NE differentiation in human prostate cancer has a negative prognostic significance. Circulating CgA levels reflect immunohistochemical findings...
Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancerJ Horiguchi
Second Department of Surgery, Gunma University Faculty of Medicine, Showa machi 3 39 15, Maebashi, Gunma 371 8511, Japan
Br J Cancer 86:222-5. 2002..In conclusion, dihydropyrimidine dehydrogenase is a possible prognostic factor in patients with breast cancer treated with 5-fluorouracil or 5-fluorouracil derivatives...
Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significanceJuan Carlos de Vicente
Department of Oral and Maxillofacial Surgery, University Hospital of Oviedo, Oviedo, Spain
Oral Oncol 38:301-8. 2002..Cyclin D1 and Ki-67 overexpression were positively correlated...
The significance of monoamine oxidase-A expression in high grade prostate cancerDonna M Peehl
Department of Urology, Stanford University School of Medicine, Stanford, California, USA
J Urol 180:2206-11. 2008..We investigated whether monoamine oxidase-A expression correlates with another basal cell protein, CD44, in high grade cancer and whether either is associated with an aggressive phenotype...
Loss of 14-3-3 sigma protein expression and presence of human papillomavirus type 16 E6 in oral squamous cell carcinomaUjjal K Bhawal
BDS, Department of Diagnostic Science, Division of Pathology and High Tech Research Center, Kanagawa Dental College, Yokosuka 238 8580, Japan
Arch Otolaryngol Head Neck Surg 134:1055-9. 2008..14-3-3 Sigma is an exclusive epithelial marker, and data on its expression in different malignancies are very scarce...
CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiationC Jones
The Ludwig Institute for Cancer Research UCL Breast Molecular Pathology Group, Royal Free and University College Medical School, UK
Br J Cancer 85:422-7. 2001..Therefore it appears that grade III invasive ductal carcinomas contain a subset of tumours with specific morphological and cytogenetic characteristics, and probably prognosis for the patient...
Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinomaAkikazu Kawase
Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Int J Cancer 123:1053-9. 2008..092). The results of this study highlight the importance of podoplanin expression by CAFs and provide new insights into the biology of the cancer microenvironment in adenocarcinoma of the lung...
Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancerJ Fanning
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Richard D Ruppert Health Center, Medical College of Ohio, 3120 Glendale Avenue, Toledo, OH 43614 5809, USA
Int J Gynecol Cancer 12:286-9. 2002..19-.96). Only stage and grade were predictive of tumor recurrence (P = 0.04,.02). We conclude that in completely staged high risk endometrial cancer, commonly used immunohistochemical risk factors are not predictive for recurrence...
Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lungMizuki Ikehara
Department of Thoracic Oncology, Kanagawa Cancer Center, Asahi-ku, Yokohama 241-0815, Japan
Oncol Rep 9:835-8. 2002..014; Wilcoxon test, p=0.021). It can be concluded that the expression of survivin in tumor cells is a factor of poor prognosis in patients with small adenocarcinoma of the lung...
Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapyNoppadol Larbcharoensub
Department of Pathology, Faculty of Medicine at Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Hum Pathol 39:837-45. 2008..041) and disease-free survival (P = .001). MRP1 expression can therefore be used as a potent molecular risk factor and a guide for chemotherapeutic regimens in patients with advanced stages of NPC...
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancerNicole J McCarthy
Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20889, USA
Clin Cancer Res 8:3857-62. 2002..02; Bonferroni test). CONCLUSIONS: These data suggest that there is an increased MVD in breast cancer with the inflammatory phenotype as compared with breast cancer without the inflammatory phenotype...
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic markerG M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Cancer Res 61:7811-8. 2001..We conclude that KLK9 is a potential new independent favorable prognostic marker for early stage, low-grade, optimally debulked ovarian cancer patients...
p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosisM J Pellikainen
Department of Pathology and Forensic Medicine, University of Kuopio, FIN-70211 Kuopio, Finland
J Clin Pathol 56:214-20. 2003..001) and advanced stage (p < 0.001). CONCLUSIONS: The regulation of p21(WAF1) seems to occur independently of p53 or AP-2 and analysing p21(WAF1) expression provided no prognostic information for patients with breast cancer...
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancerD Santini
Department of Medical Oncology, University Campus Bio Medico, via Emilio Longoni 81, 00155 Rome, Italy
Ann Oncol 19:724-8. 2008....
Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancersY L Chang
Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 100, Taiwan
Br J Cancer 89:320-6. 2003..001). Notably, p53 overexpression was associated with distant metastasis of patients in the whole series (P=0.027) and in adenocarcinoma (P=0.001). It was also associated with a poorer survival of patients with adenocarcinoma (P=0.032)...
Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancerWalter P Carney
Oncogene Science, Bayer HealthCare, Cambridge, MA 02142, USA
Clin Breast Cancer 5:105-16. 2004....
Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasmsSteven R Hustinx
Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
Cancer Biol Ther 4:596-601. 2005..4; 0.9-2.2, p = 0.14). Aberrant expression of 14-3-3sigma may contribute to the outcome of patients with pancreatic ductal adenocarcinoma...
Expression of IAP family proteins in colon cancers from patients with different age groupsT Endo
Department of Pathology and Immunology, Graduate School, Tokyo Medical and Dental University, 1 5 45 Yushima, Bunkyo ku, Tokyo 113 8519, Japan
Cancer Immunol Immunother 53:770-6. 2004..These results suggest that the expression of IAP family proteins, especially survivin, is associated with the age-related biological characteristics of colon cancer...
Apoptosis in prostate cancer: bax correlation with stageZahra Amirghofran
Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
Int J Urol 12:340-5. 2005..CONCLUSION: The patients in the present study showed a different pattern of apoptosis positivity compared to other reports. Bax expression may be a useful marker for prognosis of prostate cancer...
Prognostic values of KAI1 and survivin expression in an infiltrating ductal carcinoma of the breastB H Son
Department of General Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine [corrected] Seoul, Korea
Pathology 37:131-6. 2005..Four different groups, according to their survivin and KAI1 expression levels, correlated with the clinical stage and survival rate. CONCLUSION: KAI1 and survivin expression levels might be prognostic factors in breast cancers...
Elevated cyclooxygenase-2 expression in patients with early gastric cancer in the gastric pylorusHiroshi Yasuda
Division of Gastroenterology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Yokohama, 227-8501, Japan
J Gastroenterol 40:690-7. 2005..Bile acids induced COX-2 expression in human gastric cell lines, suggesting a role of bile reflux in gastric carcinogenesis...
Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: correlation with DNA contentAyman El Meghawry El-Kenawy
Molecular Biology Department, Genetic Engineering and Biotechnology Research Institute, Minufiya University, Sadat City, Minufiya, Egypt
J Clin Gastroenterol 39:791-4. 2005..The present study was carried out to evaluate the correlation between vascular endothelial cell marker (CD34), matrix metalloproteinase type 9 (MMP9), and DNA content in esophageal carcinoma...
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic markerEmma Bragantini
Dipartimento di Patologia, Sezione Anatomia Patologica, Universita di Verona, Strada Le Grazie, 8, 37134, Verona, Italy
J Cancer Res Clin Oncol 132:45-50. 2006..050). While loss of Fhit correlates with poorer survival in univariate analysis, it is not an independent prognostic factor in multivariate analysis and is thus not of clinical utility...
Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokersT Dutu
Department of Medicine, Institut Gustave Roussy, Villejuif, France
Ann Oncol 16:1906-14. 2005..High levels of EGFR and Ki-67 are observed in smokers, while never-smokers are characterized by high levels of pAKT and p27...
Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patientsAya Nishizawa
Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
Cancer 103:1693-700. 2005..Recently, the authors reported a novel cell membrane glycoprotein, dysadherin, which has an anti-cell-cell adhesion function and down-regulates E-cadherin...
Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancerDaniel G Rosen
Departments of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 11:632-7. 2005....
Research Grants
- Early Biomarkers of Lung cancer by Gene Array AnalysisSusan Boggs; Fiscal Year: 2003..Expression profiling is expected to provide a new approach for comparisons between normal and cancerous cells, as well as to suggest potential targets for intervention. ..
- Protein Biomarkers of Cancer Risk in Older PersonsChristopher Li; Fiscal Year: 2007....
- Phase II Study of 44Gy from 131I-81C6 for CNS TumorsDavid Reardon; Fiscal Year: 2004..To further define the toxicity of this approach and Specific Aim 3.To determine the impact of this therapy on quality of life. ..
- P21 INDUCTION BY BRCA2Fergus Couch; Fiscal Year: 2002....
- Molecular signatures of HNSCC in response to targeted therapiesChristine Chung; Fiscal Year: 2009..Ultimately, we expect that the findings from this study will be translated into improved patient selection and optimized treatment benefits from EGFR inhibitors in HNSCC patients. ..
- Molecular signatures of HNSCC in response to targeted therapiesChristine Chung; Fiscal Year: 2007..Ultimately, we expect that the findings from this study will be translated into improved patient selection and optimized treatment benefits from EGFR inhibitors in HNSCC patients. ..
- Methodology of Phase I and II trials of anticancer CAMAndrew Vickers; Fiscal Year: 2004....
- CLINICAL RESEARCH CURRICULUMDavid Ransohoff; Fiscal Year: 2004..abstract_text> ..
- BRCA2 missense mutations and breast cancerFergus Couch; Fiscal Year: 2009..relevance of many missense mutations will have been determined and provided to the carriers who will then be able to benefit from improved cancer risk assessment, cancer prevention and perhaps even therapeutic strategies ..
- BRCA2 missense mutations and breast cancerFergus Couch; Fiscal Year: 2007..study the cancer relevance of many missense mutations will have been determined and provided to the carriers who will then be able to benefit from improved cancer risk assessment, cancer prevention and perhaps even therapeutic strategies ..
- BRCA2 missense mutations and breast cancerFergus Couch; Fiscal Year: 2009..study the cancer relevance of many missense mutations will have been determined and provided to the carriers who will then be able to benefit from improved cancer risk assessment, cancer prevention and perhaps even therapeutic strategies ..
- Genetic epidemiology of cell division regulation in breast cancerFERGUS JOSEPH COUCH; Fiscal Year: 2010..The results will provide information for improved risk assessment and could provide targets for breast cancer prevention and therapeutic agents. ..
- Genetic epidemiology of cell division regulation in breast cancerFergus Couch; Fiscal Year: 2009..The results will provide information for improved risk assessment and could provide targets for breast cancer prevention and therapeutic agents. ..
- BRCA2 missense mutations and breast cancerFERGUS JOSEPH COUCH; Fiscal Year: 2010..relevance of many missense mutations will have been determined and provided to the carriers who will then be able to benefit from improved cancer risk assessment, cancer prevention and perhaps even therapeutic strategies ..
- Colonoscopy Utilization in North CarolinaDavid Ransohoff; Fiscal Year: 2006..It may provide the basis to develop interventions to optimize the allocation of colonoscopy effort in programs of CRC screening and surveillance. ..
- Novel Methods for Integrative Analysis of Cancer Genomic DataShuangge Ma; Fiscal Year: 2010..Applications of the proposed methods will lead to identification of clinically useful cancer markers. ..
- Characterization of the Chromosome 17q23 AmpliconFergus Couch; Fiscal Year: 2006..Thus, the project may involve a complete transition from benchtop to bedside. Finally, the amplified and overexpressed genes may prove useful as important targets of gene, pharmacological, and immunological therapy in the future. ..
- A genome-wide association study for breast cancer in BRCA1 mutation carriersFERGUS JOSEPH COUCH; Fiscal Year: 2010..The modifiers may also lead to development of improved risk assessment models that better discriminate between high and lower risk BRCA1 mutation carriers. ..
- CORI: Consortium Expansion and Database EnhancementDavid Lieberman; Fiscal Year: 2004....
- Interaction of PTEN and CDKN1B in Pca susceptibilityJianfeng Xu; Fiscal Year: 2007..The results from this study are likely to significant advance our knowledge of prostate cancer risk and begin to explore the underlying biological mechanisms for any observed differences. ..
- Clinical Outcomes Research: An Endoscopic Data BaseDavid Lieberman; Fiscal Year: 2007..Theme 4: Provide a resource to the scientific community. We have demonstrated successful collaboration with a wide range of clinical investigators to develop projects that are uniquely suited to a large community-based practice network. ..
- DNA Adducts of the Carcinogen AcetaldehydeStephen Hecht; Fiscal Year: 2007..These studies will provide critical data on the occurrence and biological significance of acetaldehyde DNA adducts and their possible role in human cancer. ..
- Telomere dysfunction, oxidative damage and breast cancer riskJing Shen; Fiscal Year: 2007....
- Oral Cancer, Chemoprevention, and Anti-AngiogenesisMark Lingen; Fiscal Year: 2009..abstract_text> ..
- Molecular physiology of mammalian INSP3 receptorJ Kevin Foskett; Fiscal Year: 2009..The results of these studies should provide new insights into the molecular physiology of this ubiquitous family of Ca2+ release channels. ..
- Cytosolic O-Glycosylation and Insulin SignalingGerald Warren Hart; Fiscal Year: 2010..Data from these experiments will reveal totally new avenues for developing treatments for diabetes. ..
- Phase III Trial of Exercise Training in Postsurgical Lung CancerLee Jones; Fiscal Year: 2009..Despite its importance, effective interventions to improve exercise capacity among lung cancer patients are not available. ..
- Genetic Determinants of Lung Cancer SurvivalPing Yang; Fiscal Year: 2010..Our ultimate goal is to build comprehensive and clinically useful models in designing patient-specific treatment plans and in predicting patients'treatment response and survival. ..
- A Serum Marker for Aggressive Prostate CancerDonna M Peehl; Fiscal Year: 2010....
- Tamoxifen & Second Breast Cancer: Epidemiology/PathologyChristopher Li; Fiscal Year: 2007..which women have increased or decreased risks of developing CBC if they use tamoxifen? (4) Among the CBC cases, how does tamoxifen alter the expression of these tumor markers in first compared to contralateral cancers? ..
- Molecular Profiling of Premalignant Oral LesionsMark Lingen; Fiscal Year: 2007..This molecular analysis may also greatly improve diagnostic prediction compared to the cellular pattern recognition currently used by pathologists. ..
- Advancing Child Health through Cellular and Molecular BiologyValerie Castle; Fiscal Year: 2007....
- Depo-Provera and Breast Cancer: Epidemiology/PathologyChristopher Li; Fiscal Year: 2009..such as parity and body mass index, modify this association?; and (3) Does the association between DMPA and breast cancer risk vary by histologic type or by the expression of steroid receptors including ERq, ERft, and PR? ..
- Risk Factors for Second Primary Breast Cancer Among DCIS SurvivorsChristopher I Li; Fiscal Year: 2010....
- KALLIKREINS AS DIAGNOSTIC MARKERS OF OVARIAN CARCINOMAEleftherios Diamandis; Fiscal Year: 2007..Relevance of this research to public health: By achieving early ovarian cancer diagnosis, it will be possible to reduce the burden of the disease by administration of effective treatment as early as possible. ..
- c-erbB-2 and Risk of Contralateral Breast CancerChristopher Li; Fiscal Year: 2007....
- ER Reporter Genes To Predict Response To Endocrine TherapyWILLIAM SYMMANS; Fiscal Year: 2007....
- A Serum Marker for Aggressive Prostate CancerDonna Peehl; Fiscal Year: 2007....
- Molecular Mechanisms in the Treatment of NeuroblastomaValerie Castle; Fiscal Year: 2005..abstract_text> ..
- Analysis to enhance sensitivity for membrane proteinsSamir Hanash; Fiscal Year: 2002....
- ORAL CANCER, RETINOIDS, AND ANTIANGIOGENESISMark Lingen; Fiscal Year: 2002....
